GCR Live: Law Leaders Global 2025
On January 30, Axinn partner Bradley Justus will speak on the “Antitrust: Theories of Harm in Unilateral Conduct Cases Concerning Big Tech in the U.S. and Europe” panel at Global Competition Review’s Law Leaders Global Conference, being held January 29-31 in Miami.
Axinn Antitrust Insight: FTC Announces Revised HSR Thresholds for 2025
What You Need to Know
Transactions valued at over $126.4 million will require HSR premerger notification in 2025. The updated thresholds are expected to take effect for transactions closing in mid- to late February 2025.
Four Axinn Thought Leadership Pieces Nominated for the Antitrust Writing Awards
Four written pieces authored by Axinn lawyers have been nominated for the Concurrences 2025 Antitrust Writing Awards. These awards aim to promote competition scholarship and contribute to competition advocacy. Axinn’s lawyers have consistently been recognized in previous nominations over the years.
GCR Live: Law Leaders Global 2025
On January 30, Axinn partner Bradley Justus will speak on the “Antitrust: Theories of Harm in Unilateral Conduct Cases Concerning Big Tech in the U.S. and Europe” panel at Global Competition Review’s Law Leaders Global Conference, being held January 29-31 in Miami.
Axinn Antitrust Insight: FTC Announces Revised HSR Thresholds for 2025
What You Need to Know
Transactions valued at over $126.4 million will require HSR premerger notification in 2025. The updated thresholds are expected to take effect for transactions closing in mid- to late February 2025.
Four Axinn Thought Leadership Pieces Nominated for the Antitrust Writing Awards
Four written pieces authored by Axinn lawyers have been nominated for the Concurrences 2025 Antitrust Writing Awards. These awards aim to promote competition scholarship and contribute to competition advocacy. Axinn’s lawyers have consistently been recognized in previous nominations over the years.
GCR Live: Law Leaders Global 2025
On January 30, Axinn partner Bradley Justus will speak on the “Antitrust: Theories of Harm in Unilateral Conduct Cases Concerning Big Tech in the U.S. and Europe” panel at Global Competition Review’s Law Leaders Global Conference, being held January 29-31 in Miami.
Antitrust
Axinn’s full-service antitrust practice stands among the largest and most experienced. Our team works coast to coast and across borders to deliver integrated counsel on mergers and acquisitions (M&A), litigation, and government investigations.
Global Leader in Antitrust
Celebrated as a top-ranked antitrust practice by Chambers and Partners and Global Competition Review, Axinn is renowned for representing some of the world’s largest companies in matters of the highest strategic importance. Our track record of success includes leading high-profile civil and criminal litigations and investigations. Orchestrating approximately half a trillion dollars in M&A transactions, we have gained clearances for intensely contested deals, including the largest cash merger in U.S. history, the largest-ever tech deal, and other landmark transactions.
Unmatched Experience
We don't just understand the government authorities you'll face – we have inside agency experience. Our team of more than 70 dedicated antitrust lawyers includes former high-ranking officials from the Federal Trade Commission (FTC) and U.S. Department of Justice (DOJ) as well as European Union antitrust regulators. Our dual perspective and experience enable us to tackle the most challenging multinational antitrust issues.
Deep Commitment to Client Success
Invested in our clients' success, we provide in-depth analysis and dedicated advocacy. Our inquisitive and incisive approach enables us to navigate the most complex legal issues with precision. We value collaboration and inclusivity, evidenced by our success in leading multijurisdictional teams to resolve sprawling litigations and advance cross-border deals.
Our reputation as tenacious advocates for strategic transactions is built on our track record of obtaining global clearances for multibillion-dollar deals combining industry rivals.
Axinn lawyers regularly serve as lead counsel, overseeing co-counsel around the world. Our diverse perspectives and experience make us adept at developing cohesive strategies to address regulators’ concerns head-on and gain approvals in the most challenging jurisdictions.
Experience:
- Broadcom’s $69 billion acquisition of VMware.
- Dell’s $67 billion acquisition of EMC.
- Thermo Fisher Scientific’s $13.2 billion acquisition of Life Technologies and $12.5 billion tender offer to acquire QIAGEN .
Axinn’s substantial experience as lead counsel in Section 7 challenges to mergers includes:
- Obtained a judgment rejecting the DOJ’s bid to block SunGard’s $825 million acquisition of Comdisco’s business recovery assets.
- Successfully litigated against the DOJ’s attempt to block George’s Inc.'s sale of assets to Tyson Foods after the sale had been completed.
- Successfully litigated against the City of New York in its efforts to stop Group Health Inc.'s acquisition of HIP Insurance Company.
Employing a sophisticated yet practical approach, Axinn has defended major industry players in some of the most high-profile and complex antitrust litigations and deal reviews in recent history. From private treble-damage class actions and sprawling multidistrict litigations (MDL) to price-fixing, bid-rigging, market allocation, and other antitrust claims, we resolve cases strategically and efficiently. Our experience extends to monopolization disputes, merger trials, criminal defense, and internal investigations.
Our inquisitive nature drives us to explore all facets of antitrust claims, ensuring comprehensive and diligent representation across industries. We consistently apply our creativity and bottom-line perspective to achieve exceptional outcomes in matters involving third-party subpoena defenses, leniency applications, antitrust compliance, and government investigations.
Experience:
- Representing Tyson Foods in multiple class action lawsuits alleging collusion among competitors.
- Representing Alvogen in the sprawling Generic Drugs MDL and in its antitrust counterclaims against Indivior relating to Alvogen’s launch of a generic equivalent to SUBOXONE®sublingual film.
- Representing Momenta Pharmaceuticals in a monopolization and class action lawsuit.
In today’s aggressive enforcement environment, the choice of cartel counsel is crucial. Lawyers must be incisive advisors, inquisitive strategists, and invested advocates. Axinn embodies these qualities.
We pride ourselves on handling the two largest price-fixing investigations of the past decade. We’ve represented clients in cartel investigations by major global authorities, including:
- DOJ
- Australian Competition and Consumer Commission
- Brazil’s Administrative Council for Economic Defense
- Canadian Competition Bureau
- European Commission
Our ranks include former federal prosecutors and leaders from the DOJ Antitrust Division who have overseen criminal investigations, trials, and policy initiatives. Leveraging our government experience, we take an integrated approach to managing all aspects of representation: compliance programs; internal investigations; government probes; criminal proceedings; and civil litigation.
We understand that each client’s goals and challenges are unique and devise tailored, creative strategies to resolve investigations.
We excel in leading complex matters at the intersection of antitrust and intellectual property (IP) laws. Combining our advanced technical training and focused IP experience, we regularly advise on standard-setting and fair, reasonable, and nondiscriminatory issues.
Clients call on us to conduct thorough internal investigations and to develop and implement robust antitrust compliance programs. Our client-centric approach empowers clients to navigate the most challenging antitrust landscapes with confidence.
Experience:
- Representing Google before FTC with respect to Standard Essential Patents
- Representing Red Hat before DOJ with respect to patent acquisitions
- Representing Motorola Mobility before FTC regarding patent issues
Insights
Event
|February 27, 2025
American Bar Association 2025 Asia-Pacific Conference
On February 28, Axinn partner Tiffany Rider will speak on the "Ready for a Dawn Raid in the Digital Era?" panel at the American Bar Association's Asia-Pacific Conference, being held February 26-28 in Singapore. ...Read more
Event
|February 20, 2025
NBA Commercial Law Section 38th Annual Corporate Counsel Conference
Axinn is pleased to announce its sponsorship of the National Bar Association Commercial Law Section's Corporate Counsel Conference, being held February 20-22 in Fajardo, Puerto Rico. ...Read more
Event
|January 30, 2025
GCR Live: Law Leaders Global 2025
On January 30, Axinn partner Bradley Justus will speak on the "Antitrust: Theories of Harm in Unilateral Conduct Cases Concerning Big Tech in the U.S. and Europe" panel at Global Competition Review's Law Leaders Global Conference, being held January 29-31 in Miami. ...Read more
Event
|January 26, 2025
SABA North America Corporate Counsel Retreat 2025
Axinn is pleased to announce its sponsorship of the South Asian Bar Association of North America’s Corporate Counsel Retreat, being held January 26-28 in Charlotte, North Carolina. ...Read more
Publications
|January 13, 2025
|3 min read
Axinn Antitrust Insight: FTC Announces Revised HSR Thresholds for 2025
What You Need to Know...Read more
News
|January 13, 2025
|1 min read
Four Axinn Thought Leadership Pieces Nominated for the Antitrust Writing Awards
Four written pieces authored by Axinn lawyers have been nominated for the Concurrences 2025 Antitrust Writing Awards. These awards aim to promote competition scholarship and contribute to competition advocacy. Axinn’s lawyers have consistently been recognized in previous nominations over the years....Read more
Publications
|January 10, 2025
|less than 1 min read
Merger Remedies Back in Vogue Under Trump
Axinn partner and chief diversity, equity & inclusion officer Leslie Overton was quoted in The Deal article, "Merger Remedies Back in Vogue Under Trump. ...Read more
News
|January 2, 2025
|2 min read
Axinn Promotes Michael O’Mara to Partner, Lindsey Strang Aberg, Ali Vissichelli, Eva Yung to Counsel
Axinn, Veltrop & Harkrider LLP announced today that it has promoted Michael O’Mara to partner and Lindsey Strang Aberg, Ali Vissichelli, and Eva Yung to counsel, effective January 1, 2025. Michael, Lindsey, Ali, and Eva work across Axinn’s antitrust and litigation practices. ...Read more
Publications
|December 23, 2024
|less than 1 min read
Managing partner Jeny Maier co-hosts this episode of Our Curious Amalgam with Sergei Zaslavsky (O’Melveny) and is joined by guest Dan Graulich (Baker & McKenzie ) to explore the history of FTC Act Section 5 enforcement and the FTC’s 2022 Section 5 Policy Statement....Read more
Publications
|December 20, 2024
|less than 1 min read
Forecasting Health Care Antitrust Under a Second Trump Administration
Partner Lisl Dunlop speaks with Mark Seidman, partner at Weil Gotshal & Manges LLP, for the American Health Law Association's Speaking of Health Law podcast about some of the potential health care antitrust priorities of a second Trump Administration. They discuss the incoming administration’s potential approaches to the new Merger Guidelines, hospital merger enforcement, focus on labor market impacts, private equity in health care, and the FTC’s rule banning non-competes....Read more
Practice Chair
Featured Insights
Featured Insights
American Bar Association 2025 Asia-Pacific Conference
Speaking Engagement
Antitrust
NBA Commercial Law Section 38th Annual Corporate Counsel Conference
Sponsorship
Antitrust
GCR Live: Law Leaders Global 2025
Speaking Engagement
Antitrust
The 32nd Annual Marketing Partner Forum
Event
SABA North America Corporate Counsel Retreat 2025
Sponsorship
Antitrust
Axinn Antitrust Insight: FTC Announces Revised HSR Thresholds for 2025
Client Alerts
Antitrust
Four Axinn Thought Leadership Pieces Nominated for the Antitrust Writing Awards
Awards & Recognitions
Antitrust
Merger Remedies Back in Vogue Under Trump
Media Mentions
Antitrust
Three Takeaways from the Initial Determination at the ITC Regarding Standard Essential Patents in the 1380 Investigation
Axinn Viewpoints
Intellectual Property
A POSA’s Motivation Is Not Required To Be the Same as the Inventor’s in Evaluating Obviousness
Axinn Viewpoints
Intellectual Property